Literature DB >> 25102383

Comorbidity and functional mobility in persons with Parkinson disease.

Laurie A King1, Kelsey C Priest2, John Nutt2, Yiyi Chen3, Zunqiu Chen3, Marsha Melnick4, Fay Horak2.   

Abstract

OBJECTIVES: To report the frequency, severity, and types of comorbidities in people with Parkinson disease (PD) using a validated self-report comorbidity screening tool, and to determine the relationship between comorbidity and functional mobility.
DESIGN: A secondary analysis and cross-sectional observational study design.
SETTING: University hospital; outpatient balance disorders laboratory. PARTICIPANTS: Persons with mild to moderate idiopathic PD (N=76). INTERVENTION: Not applicable. MAIN OUTCOME MEASURES: The Cumulative Illness Rating Scale-Geriatric (CIRS-G) and a comprehensive mobility assessment including gait (distance walked in 3 min), balance (mini-Balance Evaluation Systems Test), and physical function (Physical Performance Test).
RESULTS: All participants reported comorbidities in addition to their diagnosed PD. The average ± SD number of comorbidities was 6.96 ± 2.0 (range, 2-11), and the total CIRS-G score ± SD was 12.7 ± 4.8. The most commonly reported organ systems with comorbidity were eyes and ears (89%), psychiatric (68%), musculoskeletal (64%), lower gastrointestinal (62%), respiratory (60.5%), upper gastrointestinal (59.2%), and genitourinary (53.9%). The total CIRS-G score was significantly related to functional mobility: gait (r=-.53, P=.0001), balance (r=-.43, P=.0003), and physical performance (r=-.36, P=.0041). Of the original 14 organ systems measured, there were 7 systems that, when combined, best predicted gait performance, 6 systems combined that best predicted balance performance, and 4 systems combined that predicted functional performance.
CONCLUSIONS: This study reports a high frequency of multiple medical system comorbidity in people with mild to moderate PD. Furthermore, comorbidity scores were associated with mobility disability: gait, balance, and physical function. Early intervention is important to delay mobility disability in PD, and we recommend that people with PD found to have comorbidities should be screened for balance and gait deficits.
Copyright © 2014 American Congress of Rehabilitation Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Comorbidity; Parkinson disease; Postural balance; Rehabilitation

Mesh:

Year:  2014        PMID: 25102383      PMCID: PMC4322903          DOI: 10.1016/j.apmr.2014.07.396

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  28 in total

1.  Prevalence of depression and its treatment in an elderly population: the Cache County study.

Authors:  D C Steffens; I Skoog; M C Norton; A D Hart; J T Tschanz; B L Plassman; B W Wyse; K A Welsh-Bohmer; J C Breitner
Journal:  Arch Gen Psychiatry       Date:  2000-06

2.  An objective measure of physical function of elderly outpatients. The Physical Performance Test.

Authors:  D B Reuben; A L Siu
Journal:  J Am Geriatr Soc       Date:  1990-10       Impact factor: 5.562

3.  Muscular weakness in Parkinson's disease.

Authors:  S Yanagawa; M Shindo; N Yanagisawa
Journal:  Adv Neurol       Date:  1990

4.  Incidence and prediction of falls in Parkinson's disease: a prospective multidisciplinary study.

Authors:  B H Wood; J A Bilclough; A Bowron; R W Walker
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-06       Impact factor: 10.154

5.  Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030.

Authors:  E R Dorsey; R Constantinescu; J P Thompson; K M Biglan; R G Holloway; K Kieburtz; F J Marshall; B M Ravina; G Schifitto; A Siderowf; C M Tanner
Journal:  Neurology       Date:  2006-11-02       Impact factor: 9.910

6.  Reasons for admission to hospital for Parkinson's disease.

Authors:  J A Temlett; P D Thompson
Journal:  Intern Med J       Date:  2006-08       Impact factor: 2.048

7.  The Montreal cognitive assessment as a screening tool for cognitive impairment in Parkinson's disease.

Authors:  David J Gill; Arielle Freshman; Jennifer A Blender; Bernard Ravina
Journal:  Mov Disord       Date:  2008-05-15       Impact factor: 10.338

8.  Lateral stepping for postural correction in Parkinson's disease.

Authors:  Laurie A King; Fay B Horak
Journal:  Arch Phys Med Rehabil       Date:  2008-03       Impact factor: 3.966

9.  A comparison of the mini mental state exam to the Montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease.

Authors:  Cindy Zadikoff; Susan H Fox; David F Tang-Wai; Teri Thomsen; Rob M A de Bie; Pettarusup Wadia; Janis Miyasaki; Sarah Duff-Canning; Anthony E Lang; Connie Marras
Journal:  Mov Disord       Date:  2008-01-30       Impact factor: 10.338

10.  Prognostic importance of comorbidity in a hospital-based cancer registry.

Authors:  Jay F Piccirillo; Ryan M Tierney; Irene Costas; Lori Grove; Edward L Spitznagel
Journal:  JAMA       Date:  2004-05-26       Impact factor: 56.272

View more
  13 in total

1.  Effects of 2 Years of Exercise on Gait Impairment in People With Parkinson Disease: The PRET-PD Randomized Trial.

Authors:  Miriam R Rafferty; Janey Prodoehl; Julie A Robichaud; Fabian J David; Cynthia Poon; Lisa C Goelz; David E Vaillancourt; Wendy M Kohrt; Cynthia L Comella; Daniel M Corcos
Journal:  J Neurol Phys Ther       Date:  2017-01       Impact factor: 3.649

2.  Interdisciplinary Home Visits for Individuals with Advanced Parkinson's Disease and Related Disorders.

Authors:  Jori Fleisher; William Barbosa; Meghan M Sweeney; Sarah E Oyler; Amy C Lemen; Arash Fazl; Mia Ko; Talia Meisel; Naomi Friede; Geraldine Dacpano; Rebecca M Gilbert; Alessandro Di Rocco; Joshua Chodosh
Journal:  J Am Geriatr Soc       Date:  2018-04-02       Impact factor: 5.562

3.  Functional Aspects of Gait in Essential Tremor: A Comparison with Age-Matched Parkinson's Disease Cases, Dystonia Cases, and Controls.

Authors:  Elan D Louis; Ashwini K Rao
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2015-05-27

4.  Co-morbidity and polypharmacy in Parkinson's disease: insights from a large Scottish primary care database.

Authors:  Gary McLean; John V Hindle; Bruce Guthrie; Stewart W Mercer
Journal:  BMC Neurol       Date:  2017-07-01       Impact factor: 2.474

5.  Anticholinergic burden and comorbidities in patients attending treatment with trospium chloride for overactive bladder in a real-life setting: results of a prospective non-interventional study.

Authors:  A Ivchenko; R-H Bödeker; C Neumeister; A Wiedemann
Journal:  BMC Urol       Date:  2018-09-14       Impact factor: 2.264

6.  Patient Safety in a Box: Implementation and Evaluation of the Emergency Box in Geriatric and Parkinson Patients.

Authors:  Lea Krey; Pia Lange; Anh Thu Tran; Stephan Greten; Günter U Höglinger; Florian Wegner; Olaf Krause; Martin Klietz
Journal:  J Clin Med       Date:  2021-11-29       Impact factor: 4.241

7.  Is PIGD a legitimate motor subtype in Parkinson disease?

Authors:  Vikas Kotagal
Journal:  Ann Clin Transl Neurol       Date:  2016-05-11       Impact factor: 4.511

8.  Medication use and falls: Applying Beers criteria to medication review in Parkinson's disease.

Authors:  Eleanor Yusupov; Davina Chen; Bhuma Krishnamachari
Journal:  SAGE Open Med       Date:  2017-11-20

9.  Association of Strength and Physical Functions in People with Parkinson's Disease.

Authors:  Sacha Clael; Elaine Brandão; Liana Caland; Raquel Techmeier; Tamara de Paiva; Jhonatan Rodrigues; Camila Wells; Lídia Bezerra
Journal:  Neurosci J       Date:  2018-12-12

10.  Simultaneously Improved Pulmonary and Cardiovascular Autonomic Function and Short-Term Functional Outcomes in Patients with Parkinson's Disease after Respiratory Muscle Training.

Authors:  Chih-Cheng Huang; Yun-Ru Lai; Fu-An Wu; Nai-Ying Kuo; Yuh-Chyn Tsai; Ben-Chung Cheng; Nai-Wen Tsai; Cheng-Hsien Lu
Journal:  J Clin Med       Date:  2020-01-22       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.